Search
Close this search box.
Search
Close this search box.

Africa

Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development

BSPG Laboratories VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) — Brains Bioceutical Corp. (Brains Bio), a global leader in natural, GMP-compliant cannabinoid Active Pharmaceutical Ingredients (APIs), announces the expansion of its industry-leading offering. Cannabinol (CBN) is available as an EU-GMP certified API, D9-Tetrahydrocanabinol (THC) is in a solid crystalline

Read More

Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development

BSPG Laboratories VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) — Brains Bioceutical Corp. (Brains Bio), a global leader in natural, GMP-compliant cannabinoid Active Pharmaceutical Ingredients (APIs), announces the expansion of its industry-leading offering. Cannabinol (CBN) is available as an EU-GMP certified API, D9-Tetrahydrocanabinol (THC) is in a solid crystalline

Read More

Quantexa Recognized as Category Leader in Chartis’ 2024 AML Transaction Monitoring Solutions Report

The data, analytics, and AI software provider achieved “best-in-class” ratings for its anti-money laundering capabilities in data integration, modelling and workflow LONDON, Dec. 16, 2024 (GLOBE NEWSWIRE) — Quantexa, a leading provider of Decision Intelligence solutions for the public and private sectors, today announced recognition in Chartis’ RiskTech Quadrant Update

Read More